3651 results for «217»
3651 results
Revisiting thrombus aspiration in STEMI with continuous power aspiration system
15 May 2024 – From EuroPCR 2024
Tune into this 2024 session for insights into the latest ESC guidelines, strategies to prevent and treat no reflow, and an examination of trials like TASTE, TAPAS, and TOTAL on coronary thrombus management. Explore also the outcomes of the CHEETAH study, pondering a potential paradigm shift,...
Ultra-low contrast techniques to improve the safety and quality of PCI in complex and high-risk patients
14 May 2024 – From EuroPCR 2024
Tune in to this session to discover how reducing reliance on contrast opacification enhances procedural safety and enables more thorough revascularization in complex PCI scenarios. Learn that ultra-low contrast (ULC) PCI encompasses various interventional skills and specialized tools, many already familiar to interventional cardiologists. Embrace a...
Solving challenging PCI with laser atherectomy: the forgotten Swiss knife?
15 May 2024 – From EuroPCR 2024
Watch this session to enhance your understanding of laser atherectomy fundamentals, recognize its role in addressing complex lesions like in-stent restenosis and uncrossable lesions, and acquire tips and techniques for ensuring procedural efficiency and safety.
uRDN now - The third pillar for hypertension treatment
16 May 2024 – From EuroPCR 2024
Tune into this session to stay updated on the cutting-edge clinical evidence, guidelines, and technology surrounding renal denervation. Explore firsthand clinical experiences with ultrasound renal denervation and gain practical insights into patient selection through individual, real-world case discussions. Engage in discussions on integrating ultrasound renal denervation...
Robotic PCI: tips and tricks, challenging anatomies and future perspectives
14 May 2024 – From EuroPCR 2024
In this session, discover the effectiveness and safety of robotic PCI for both simple and complex lesions requiring additional devices like IVL, IVUS, laser, and FFR. Learn about the numerous benefits of robotics for patients and cathlab teams, including enhanced precision in wire navigation and stent...
Cracking open the discussion on the clinical experience with intravascular lithotripsy in acute coronary syndromes
16 May 2024 – From EuroPCR 2024
Explore this session to uncover the common association between calcium and acute coronary syndrome, and how intravascular lithotripsy (IVL) offers a safe solution for calcified lesions, with comparable procedural success rates. However, note that ACS cases involving calcium may lead to higher major adverse cardiac events...
Complex PCI in ACS patient with high bleeding risk: optimise the strategy
15 May 2024 – From EuroPCR 2024
Watch this session for insights into managing acute coronary syndrome patients with multivessel disease, updates on treatment approaches, comparing FULL RESVAC with previous trials like COMPLETE or FIRE, for example, and information on ongoing trials such as FRAMI-AMI 2 and 3. Explore the LIVE case presentation...
Challenges in below-the-knee
14 May 2024 – From EuroPCR 2024
This session focuses on the challenges and strategies for below-the-knee angioplasty. It aims to define the appropriate tools for below-the-knee angioplasty, understand the incremental strategy for antegrade recanalisation and the appropriate timing for retrograde approach, and provide guidance on what to do when everything fails.
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
30 Aug 2022
Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona

Author
TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
31 Aug 2024
Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.
Simultaneous publication in European Heart Journal, ehae578

Author
EuroPCR 2024: Elixir Medical’s late-breaking 12-month data demonstrate significant improvement in safety and effectiveness of world’s first site-specific antithrombotic therapeutic compared to DES
14 May 2024